Ascend Therapeutics, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ascend Therapeutics, Inc..The latest application filed is for "treatment and prevention of benign breast disease with 4-hydroxy tamoxifen".
- Ascend Therapeutics, Inc. - Herndon VA
- Ascend Therapeutics, Inc. -
Trademarks
| Patent | Date |
|---|---|
| Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen Grant 7,767,717 - Palumbo , et al. August 3, 2 | 2010-08-03 |
| Chemically stable compositions of 4-hydroxy tamoxifen App 20050208139 - Hilt, Dana ; et al. | 2005-09-22 |
| Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen App 20050209340 - Le Nestour, Elisabeth | 2005-09-22 |
| Treatment of gynecomastia with 4-hydroxy tamoxifen App 20050158388 - Le Nestour, Elisabeth ; et al. | 2005-07-21 |
| Treatment of mastalgia with 4-hydroxy tamoxifen App 20050032909 - Lignieres, Bruno de ; et al. | 2005-02-10 |
| Prevention and treatment of breast cancer with 4-hydroxy tamoxifen App 20050031695 - Rouanet, Philippe ; et al. | 2005-02-10 |
| Reduction of breast density with 4-hydroxy tamoxifen App 20040138314 - Bua, Jay | 2004-07-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 